The CEO stepped down with company shares sinking 19% this year and the health care giant struggling on several fronts.
The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.
CVS Health said Friday that as of Thursday David Joyner became its new CEO, replacing Karen Lynch. In an agreement with the ...
The FDA approved Astellas' gastric cancer therapy. CVS Health CEO Karen Lynch steps down amid shareholder pressure, with ...
America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...
Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...